Kadmon Announces Publication of Data Demonstrating the Potential of ROCK2 Inhibition to Treat Chronic Graft-Versus-Host Disease
Data Published in the Journal Blood Kadmon to Initiate Phase 2 Study of ROCK2 Inhibitor KD025 in cGVHD in 2016 NEW YORK, NY -- (Marketwired) -- 03/21/16 -- Kadmon Corporation, LLC today announced the publication of preclinical data demonstrating that …